CIR
ZBH icon

Clear Investment Research’s Zimmer Biomet ZBH Stock Holding History

Clear Investment Research’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3
Closed – – 405
2019
Q3 		$0 Hold
3
– – ﹤0.01% 397
2019
Q2 		$0 Hold
3
– – ﹤0.01% 398
2019
Q1 		$0 Hold
3
– – ﹤0.01% 390
2018
Q4 		$0 Hold
3
– – ﹤0.01% 391
2018
Q3 		$0 Buy
+3
New +$357 ﹤0.01% 393

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Clear Investment Research's ZBH Position: Q4 2019 in Review

Clear Investment Research sold out of Zimmer Biomet (ZBH) in Q4 2019, closing a stake of 3 shares.

Clear Investment Research first reported a position in ZBH in Q3 2018 and held it in 5 quarters. The position peaked at $0 in Q3 2019. 990 funds tracked by Wall St. Rank hold ZBH as of Q4 2019.

  • Clear Investment Research reported no remaining Zimmer Biomet position as of Q4 2019 after selling out during the quarter.
  • Clear Investment Research sold 3 Zimmer Biomet shares in Q4 2019.
  • Clear Investment Research first reported a position in Zimmer Biomet in Q3 2018 and held it in 5 quarters.
  • Clear Investment Research's Zimmer Biomet position peaked at $0 in Q3 2019.
  • 990 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2019.

Based on Clear Investment Research's 13F filing for Q4 2019, filed 4 Feb 2020.